The Peptide Newsroom

Seventh Liver Toxicity Case in Victoria Prompts Warning Over Counterfeit Retatrutide Peptides

A seventh Victorian patient has been hospitalized with acute liver toxicity after using a counterfeit product labeled as retatrutide, the ABC reports. Doctors say a contaminated batch is one hypothesis, but testing results are not yet available.

Second Texas Pharmacy Recalls Injectable Compound Over Bacterial Endotoxin Risk, FDA Says

Houston-based Optimal Balance Pharmacy is recalling one lot of compounded glutathione 200 mg/mL multi-dose vials after testing found elevated bacterial endotoxin levels. The FDA said such products can cause serious reactions, and the pharmacy has received adverse event reports including fever, chills and allergic symptoms.